Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,396Revenue $M12,501Net Margin (%)10.3Altman Z-Score1.9
Enterprise Value $M4,570EPS $1.0Operating Margin %15.7Piotroski F-Score7
P/E(ttm)18.6Beneish M-Score-2.4Pre-tax Margin (%)13.7Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %--Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow22.7y-y EBITDA Growth Rate %-43.1ROA % (ttm)9.7Higher Current Ratio y-yY
Dividend Yield %1.0PEG--ROE % (ttm)19.9Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M388ROIC % (ttm)21.3Gross Margin Increase y-yN

Gurus Latest Trades with MKGAY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

MKGAY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MKGAY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about MKGAY :

    Quarterly/Annual Reports about MKGAY:

      News about MKGAY:

      Articles On GuruFocus.com

      More From Other Websites
      Merck Serono supports 7th International Thyroid Awareness Week to Unmask Hypothyroidism May 26 2015
      Merck KGaA Making Over Ambitious Growth Plans For Future? May 22 2015
      Merck Serono Announces CHMP Positive Opinion to Extend Kuvan Use to Children with PKU Below 4 Years... May 22 2015
      Merck Leads European Research Consortium on Printed Electronics May 22 2015
      Merck Millipore Introduces Single-Pass Tangential Flow Filtration with Pellicon® Cassettes for... May 21 2015
      Merck Millipore Enters Into Agreement to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive... May 21 2015
      For Displays and More: Merck Presents Expanded Portfolio and New Developments at SID Display Week... May 20 2015
      Merck Starts a Challenging 2015 with a Solid First Quarter May 19 2015
      Merck to Present Data at ASCO that Illustrate How the Company is Tackling Difficult-to-Treat Cancers May 15 2015
      Merck and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody May 13 2015
      Merck Receives FDA Fast Track Designation for Evofosfamide for Treatment of Patients Living With... May 12 2015
      Revolution in Rotomolding: Merck Develops Iriodin® RMP for Enhancing Decorative Rotational Molded... May 11 2015
      Merck Presents Organic Photovoltaic Materials at EXPO 2015 in Milan May 07 2015
      Avantor Performance Materials Holdings S.A. -- Moody's Changes Avantor's Outlook to Stable From... May 06 2015
      Study Finds Merck Millipore’s Strat-M® Synthetic Membrane Comparable to Human and Animal Skin for... May 06 2015
      Paul T. Anastas Awarded Emanuel Merck Lectureship 2015 Apr 30 2015
      Merck Millipore Introduces Magna ChIRP™ RNA Interactome Kits for the Analysis of... Apr 27 2015
      Merck Wins German Innovation Award with Liquid Crystals Apr 25 2015
      Global Strategic Partners Merck and Pfizer Initiate Phase III Study with Avelumab in Patients with... Apr 20 2015
      Merck Demonstrates Commitment to Corporate Responsibility Apr 20 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK